Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
635 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (367)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00378911 | Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |
| NCT01637961 | Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2019 | clinicaltrials |
| NCT00011414 | Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors | completed | Phase 1 | 29 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2019 | clinicaltrials |
| NCT02889848 | Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) | completed | Phase 1 | 15 | Advance Biofactures CorporationINDUSTRY | 1 | Jul 10, 2019 | clinicaltrials |
| NCT02323646 | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids | completed | Phase 2 | 42 | Repros Therapeutics Inc.INDUSTRY | 1 | Jun 25, 2019 | clinicaltrials |
| NCT00958334 | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 | completed | Phase 2 | 65 | Repros Therapeutics Inc.INDUSTRY | 1 | Jun 18, 2019 | clinicaltrials |
| NCT00341848 | Postpartum Uterine Regression | completed | — | 374 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Jun 17, 2019 | clinicaltrials |
| NCT00589121 | Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg | completed | Phase 2 | 98 | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 12, 2019 | clinicaltrials |
| NCT02546544 | Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma(LINES) | completed | Phase 2 | 16 | University of OxfordOTHER | 5 | Jun 3, 2019 | clinicaltrials |
| NCT00978471 | Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma(OSII-TTP) | completed | Phase 2 | 44 | Centre Leon BerardOTHER | 1 | May 17, 2019 | clinicaltrials |
| NCT02008877 | SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) | completed | Phase 1 / Phase 2 | 20 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT01650077 | Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria(ProAcTyon) | completed | — | 134 | Centre Oscar LambretOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT02793050 | Retrospective Study of Trabectedin in Soft Tissue Sarcomas(TrObs) | completed | — | 510 | Italian Sarcoma GroupNETWORK | 1 | May 10, 2019 | clinicaltrials |
| NCT03072446 | Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents. | completed | N/A | 11 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT03911245 | Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival | completed | — | 195 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT03798795 | Radiomics for Tumor Grading of Soft Tissue Sarcomas. | completed | — | 285 | Technical University of MunichOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03245788 | Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study | completed | N/A | 1,053 | Stanford UniversityOTHER | 1 | Apr 8, 2019 | clinicaltrials |
| NCT02565758 | ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors | completed | Phase 1 | 85 | AbbVieINDUSTRY | 3 | Apr 5, 2019 | clinicaltrials |
| NCT00767819 | Treatment of Patients With RAD001 With Progressive Sarcoma | completed | Phase 2 | 71 | Novartis PharmaceuticalsINDUSTRY | 2 | Apr 1, 2019 | clinicaltrials |
| NCT02579980 | Quantitative Imaging Biomarkers for Sarcoma | completed | N/A | 32 | Columbia UniversityOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT02655224 | A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids | completed | Phase 3 | 65 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT02655237 | A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | completed | Phase 3 | 281 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT01142791 | Safety Study of ExAblate for the Treatment of Uterine Fibroids | completed | N/A | 121 | InSightecINDUSTRY | 1 | Mar 19, 2019 | clinicaltrials |
| NCT03877588 | Nutritional Status in Retroperitoneal Sarcoma.(NOVA) | completed | N/A | 35 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 0 | Mar 15, 2019 | clinicaltrials |
| NCT00949325 | Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | completed | Phase 1 / Phase 2 | 24 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT01285960 | ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 108 | InSightecINDUSTRY | 1 | Mar 6, 2019 | clinicaltrials |
| NCT01661283 | SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors | completed | Phase 2 | 25 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT03847077 | Trial of a Patient Education Tool For Leiomyoma(PETAL) | completed | N/A | 72 | Loyola UniversityOTHER | 0 | Feb 20, 2019 | clinicaltrials |
| NCT00061893 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | completed | Phase 2 | 38 | Children's Oncology GroupNETWORK | 4 | Feb 15, 2019 | clinicaltrials |
| NCT00365989 | MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication | completed | Phase 3 | 50 | InSightecINDUSTRY | 2 | Feb 5, 2019 | clinicaltrials |
| NCT02303262 | SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma | completed | Phase 2 | 20 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT01286987 | Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors | completed | Phase 1 | 113 | PfizerINDUSTRY | 2 | Jan 10, 2019 | clinicaltrials |
| NCT03349190 | Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques(NACRE) | completed | — | 127 | ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITROOTHER | 2 | Jan 9, 2019 | clinicaltrials |
| NCT00114218 | Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer | completed | Phase 2 | 28 | Gynecologic Oncology GroupNETWORK | 1 | Jan 8, 2019 | clinicaltrials |
| NCT00295217 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation | completed | Phase 3 | 15 | InSightecINDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT01614795 | Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 2 | Dec 11, 2018 | clinicaltrials |
| NCT01696760 | Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology | completed | N/A | 12 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 5, 2018 | clinicaltrials |
| NCT00464620 | Trial of Dasatinib in Advanced Sarcomas | completed | Phase 2 | 366 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Nov 23, 2018 | clinicaltrials |
| NCT01750008 | Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions(LUSTOR) | completed | N/A | 51 | Acessa Health, Inc.INDUSTRY | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02833246 | Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications | completed | N/A | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT02204111 | Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue Sarcoma(YonLife) | completed | — | 77 | GWT-TUD GmbHOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT00283621 | Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide | completed | N/A | 51 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT00038207 | Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00283582 | Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy | completed | Phase 3 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 30, 2018 | clinicaltrials |
| NCT00348790 | Vatalanib in Treating Patients With Recurrent or Progressive Meningioma | completed | Phase 2 | 25 | Northwestern UniversityOTHER | 1 | Oct 26, 2018 | clinicaltrials |
| NCT00918489 | Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)(SAHA-I) | completed | Phase 2 | 40 | Heidelberg UniversityOTHER | 1 | Oct 17, 2018 | clinicaltrials |
| NCT00662233 | Combination Chemotherapy in Treating Patients With Sarcoma | completed | Early Phase 1 | 28 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02472184 | Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy | completed | N/A | 78 | University of South FloridaOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT00112489 | Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer | completed | Phase 2 | 55 | Gynecologic Oncology GroupNETWORK | 2 | Sep 25, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jul 23, 2019source: clinicaltrials